Dr. Scot Bradley Glasberg is a nationally recognized voice in plastic surgery, patient safety, and medical ethics — featured in The New York Times, The Washington Post, STAT News, and across broadcast media worldwide.
Silent Treatment: How WPATH Went Quiet When Asked About the Evidence
“ASPS aligned with the world's best evidence, not US institutional inertia... We just don't necessarily believe that surgery is the best course of action, given the evidence.”
The Consensus Has Been Shattered on Transgenderism
“Dr. Scot Glasberg explained that this policy change had been planned since 2024, when he was president, and was driven entirely by the lack of strong clinical evidence, not politics.”
In Tense Meeting, Mehmet Oz Pressed Medical Societies on Trans Care for Teens
“Dr. Scot Glasberg said the board had been working on changing the guidelines since 2024... Politics had absolutely zero to do with how this policy came out.”
Plastic Surgeons Ditch Gender Ideology: New Guidelines Rule Out Medical Transition for Kids
“He said the organization selected age 19 as a cutoff because by that point young people are safely out of puberty.”
Plastic Surgeons’ Group Advises Delaying Gender-Affirming Procedures Until Age 19
“Dr. Scot Glasberg said the shift had been prompted by a systematic review of existing research... The research, he said, was limited and of low quality.”
Plastic Surgeons Group Recommends Against Gender Surgery for Minors
“This is a vulnerable, adolescent population... We are mindful that some of these surgeries are irreversible.”
Plastic Surgeons Society Recommends Delaying Gender-Affirming Procedures Until Age 19
“New reviews of evidence strengthened its conclusion that the data supporting care is low quality, low certainty.”
It’s Official: No Consensus Among Medical Groups on “Gender-Affirming Care” for Minors
“The ASPS issues a bold new statement against irreversible interventions for minors.”
For interview requests, expert commentary, and media inquiries regarding Dr. Scot Bradley Glasberg. We typically respond within one business day. Or call directly: 212-717-8550